BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: An evidence-based appraisal of reflux disease management--the Genval Workshop Report. Gut. 1999;44 Suppl 2:S1-16. [PMID: 10741335 DOI: 10.1136/gut.44.2008.s1] [Cited by in Crossref: 545] [Cited by in F6Publishing: 113] [Article Influence: 24.8] [Reference Citation Analysis]
Number Citing Articles
1 Ho KY. Gastroesophageal reflux disease is uncommon in Asia: evidence and possible explanations. World J Gastroenterol 1999; 5(1): 4-6 [PMID: 11819371 DOI: 10.3748/wjg.v5.i1.4] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
2 Galmiche JP, Stephenson K. GORD and functional disorders of upper gut: . European Journal of Gastroenterology & Hepatology 2004;16:819-21. [DOI: 10.1097/00042737-200409000-00001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
3 Mastracci L, Piol N, Molinaro L, Pitto F, Tinelli C, De Silvestri A, Fiocca R, Grillo F; ABRAM Study Group. Interobserver reproducibility in pathologist interpretation of columnar-lined esophagus. Virchows Arch. 2016;468:159-167. [PMID: 26563401 DOI: 10.1007/s00428-015-1878-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
4 Maev IV, Yurenev GL, Mironova EM, Yureneva-Thorzhevskaya TV. Phenotype of obesity and gastroesophageal reflux disease in the context of comorbidity in patients with cardiovascular diseases. Ter Arkh 2019;91:126-33. [PMID: 31094183 DOI: 10.26442/00403660.2019.02.000099] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
5 Hongo M, Kinoshita Y, Haruma K. A randomized, double-blind, placebo-controlled clinical study of the histamine H2-receptor antagonist famotidine in Japanese patients with nonerosive reflux disease. J Gastroenterol 2008;43:448-56. [PMID: 18600389 DOI: 10.1007/s00535-008-2186-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
6 Roorda AK, Marcus SN, Triadafilopoulos G. Algorithmic approach to patients presenting with heartburn and epigastric pain refractory to empiric proton pump inhibitor therapy. Dig Dis Sci. 2011;56:2871-2878. [PMID: 21512760 DOI: 10.1007/s10620-011-1708-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
7 Lee SW, Chang CS. Impact of Overlapping Functional Gastrointestinal Disorders on the Quality of Life in Patients With Gastroesophageal Reflux Disease. J Neurogastroenterol Motil 2021;27:176-84. [PMID: 33795540 DOI: 10.5056/jnm19006] [Reference Citation Analysis]
8 Lee SW, Lien HC, Lee TY, Yang SS, Yeh HJ, Chang CS. Heartburn and regurgitation have different impacts on life quality of patients with gastroesophageal reflux disease. World J Gastroenterol 2014; 20(34): 12277-12282 [PMID: 25232262 DOI: 10.3748/wjg.v20.i34.12277] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
9 Iwakiri K, Kinoshita Y, Habu Y, Oshima T, Manabe N, Fujiwara Y, Nagahara A, Kawamura O, Iwakiri R, Ozawa S, Ashida K, Ohara S, Kashiwagi H, Adachi K, Higuchi K, Miwa H, Fujimoto K, Kusano M, Hoshihara Y, Kawano T, Haruma K, Hongo M, Sugano K, Watanabe M, Shimosegawa T. Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015. J Gastroenterol. 2016;51:751-767. [PMID: 27325300 DOI: 10.1007/s00535-016-1227-8] [Cited by in Crossref: 142] [Cited by in F6Publishing: 115] [Article Influence: 23.7] [Reference Citation Analysis]
10 Janssen W, Meier E, Gatz G, Pfaffenberger B. Effects of pantoprazole 20 mg in mildgastroesophageal reflux disease: Once-daily treatment in the acute phase, and comparison of on-demand versus continuous treatment in the long term. Curr Ther Res Clin Exp 2005;66:345-63. [PMID: 24672134 DOI: 10.1016/j.curtheres.2005.08.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
11 Lee KJ, Kim JI, Park JS, Moon BS, Kim SG, Chun JH, Jung HY, Choi CH, Chun SW, Song GA, Choi MG, Chun HJ. Practice pattern of gastroenterologists for the management of GERD under the minimal influence of the insurance reimbursement guideline: a multicenter prospective observational study. J Korean Med Sci 2011;26:1613-8. [PMID: 22147999 DOI: 10.3346/jkms.2011.26.12.1613] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
12 Yamagishi H, Koike T, Ohara S, Kobayashi S, Ariizumi K, Abe Y, Iijima K, Imatani A, Inomata Y, Kato K, Shibuya D, Aida S, Shimosegawa T. Prevalence of gastroesophageal reflux symptoms in a large unselected general population in Japan. World J Gastroenterol 2008; 14(9): 1358-1364 [PMID: 18322948 DOI: 10.3748/wjg.14.1358] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
13 Ponce J, Ortiz V, Maroto N, Ponce M, Bustamante M, Garrigues V. High prevalence of heartburn and low acid sensitivity in patients with idiopathic achalasia. Dig Dis Sci 2011;56:773-6. [PMID: 20676770 DOI: 10.1007/s10620-010-1343-x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
14 Röhss K, Lind T, Wilder-Smith C. Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms. Eur J Clin Pharmacol. 2004;60:531-539. [PMID: 15349707 DOI: 10.1007/s00228-004-0804-6] [Cited by in Crossref: 105] [Cited by in F6Publishing: 93] [Article Influence: 5.8] [Reference Citation Analysis]
15 Tsibouris P, Moussia M, Kalantzis C, Apostolopoulos P, Alexandrakis G, Lapas C, Kalantzis N. Endoscopic esophagitis is more severe in gastroesophageal reflux patients with a positive family history. J Clin Gastroenterol 2012;46:201-8. [PMID: 22138842 DOI: 10.1097/MCG.0b013e3182364c97] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
16 Chen CY, Lu CL, Luo JC, Chang FY, Lee SD, Lai YL. Esomeprazole tablet vs omeprazole capsule in treating erosive esophagitis. World J Gastroenterol 2005; 11(20): 3112-3117 [PMID: 15918199 DOI: 10.3748/wjg.v11.i20.3112] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
17 Scholten T. Long-term management of gastroesophageal reflux disease with pantoprazole. Ther Clin Risk Manag 2007;3:231-43. [PMID: 18360632 DOI: 10.2147/tcrm.2007.3.2.231] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
18 Goldani HA, Nunes DL, Ferreira CT. Managing gastroesophageal reflux disease in children: The role of endoscopy. World J Gastrointest Endosc 2012; 4(8): 339-346 [PMID: 22912907 DOI: 10.4253/wjge.v4.i8.339] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
19 Kellokumpu I, Voutilainen M, Haglund C, Färkkilä M, Roberts PJ, Kautiainen H. Quality of life following laparoscopic Nissen fundoplication: Assessing short-term and long-term outcomes. World J Gastroenterol 2013; 19(24): 3810-3818 [PMID: 23840119 DOI: 10.3748/wjg.v19.i24.3810] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 28] [Article Influence: 4.4] [Reference Citation Analysis]
20 Wu JC, Chan FK, Ching JY, Leung WK, Hui Y, Leong R, Chung SC, Sung JJ. Effect of Helicobacter pylori eradication on treatment of gastro-oesophageal reflux disease: a double blind, placebo controlled, randomised trial. Gut 2004;53:174-9. [PMID: 14724146 DOI: 10.1136/gut.2003.012641] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 2.6] [Reference Citation Analysis]
21 Mastracci L, Spaggiari P, Grillo F, Zentilin P, Dulbecco P, Ceppa P, Baccini P, Mansi C, Savarino V, Fiocca R. Microscopic esophagitis in gastro-esophageal reflux disease: individual lesions, biopsy sampling, and clinical correlations. Virchows Arch. 2009;454:31-39. [PMID: 19048292 DOI: 10.1007/s00428-008-0704-8] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.0] [Reference Citation Analysis]
22 Tack J, Caenepeel P, Arts J, Lee KJ, Sifrim D, Janssens J. Prevalence of acid reflux in functional dyspepsia and its association with symptom profile. Gut. 2005;54:1370-1376. [PMID: 15972301 DOI: 10.1136/gut.2004.053355] [Cited by in Crossref: 109] [Cited by in F6Publishing: 99] [Article Influence: 6.4] [Reference Citation Analysis]
23 Cho JH, Koo JY, Kim KO, Lee SH, Jang BI, Kim TN. On-demand versus half-dose continuous therapy with esomeprazole for maintenance treatment of gastroesophageal reflux disease: A randomized comparative study. Medicine (Baltimore) 2018;97:e12732. [PMID: 30412065 DOI: 10.1097/MD.0000000000012732] [Reference Citation Analysis]
24 Perry KA, Enestvedt CK, Lorenzo CS, Schipper P, Schindler J, Morris CD, Nason K, Luketich JD, Hunter JG, Jobe BA. The integrity of esophagogastric junction anatomy in patients with isolated laryngopharyngeal reflux symptoms. J Gastrointest Surg 2008;12:1880-7. [PMID: 18677538 DOI: 10.1007/s11605-008-0607-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
25 Beckerling A, Braun W, Sommer M. Process of measuring in clinical medicine--implications of different definitions in clinical therapeutic studies. Digestion 2007;75 Suppl 1:25-31. [PMID: 17489029 DOI: 10.1159/000101079] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Nomura E, Lee SW, Kawai M, Yamazaki M, Nabeshima K, Nakamura K, Uchiyama K. Functional outcomes by reconstruction technique following laparoscopic proximal gastrectomy for gastric cancer: double tract versus jejunal interposition. World J Surg Oncol 2014;12:20. [PMID: 24468278 DOI: 10.1186/1477-7819-12-20] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 5.6] [Reference Citation Analysis]
27 Morozov S, Isakov V, Konovalova M. Fiber-enriched diet helps to control symptoms and improves esophageal motility in patients with non-erosive gastroesophageal reflux disease. World J Gastroenterol 2018; 24(21): 2291-2299 [PMID: 29881238 DOI: 10.3748/wjg.v24.i21.2291] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 19] [Article Influence: 6.5] [Reference Citation Analysis]
28 Dent J, Jones R, Kahrilas P, Talley NJ. Management of gastro-oesophageal reflux disease in general practice. BMJ 2001;322:344-7. [PMID: 11159660 DOI: 10.1136/bmj.322.7282.344] [Cited by in Crossref: 72] [Cited by in F6Publishing: 65] [Article Influence: 3.4] [Reference Citation Analysis]
29 Monés J. Diagnostic value of potent acid inhibition in gastro-oesophageal reflux disease. Drugs 2005;65 Suppl 1:35-42. [PMID: 16335856 DOI: 10.2165/00003495-200565001-00006] [Reference Citation Analysis]
30 Grant AM, Cotton SC, Boachie C, Ramsay CR, Krukowski ZH, Heading RC, Campbell MK. Minimal access surgery compared with medical management for gastro-oesophageal reflux disease: five year follow-up of a randomised controlled trial (REFLUX). BMJ. 2013;346:f1908. [PMID: 23599318 DOI: 10.1136/bmj.f1908] [Cited by in Crossref: 48] [Cited by in F6Publishing: 32] [Article Influence: 5.3] [Reference Citation Analysis]
31 Fuchs KH, Feussner H. [Laparoscopic fundoplication. Indications and results]. Internist (Berl) 2003;44:36-42. [PMID: 12677703 DOI: 10.1007/s00108-002-0824-1] [Cited by in Crossref: 7] [Article Influence: 0.4] [Reference Citation Analysis]
32 Galmiche JP. Non-erosive reflux disease and atypical gastro-oesophageal reflux disease manifestations: treatment results. Drugs 2006;66 Suppl 1:7-13; discussion 29-33. [PMID: 16869343 DOI: 10.2165/00003495-200666001-00003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
33 Kamolz T, Pointner R, Velanovich V. The impact of gastroesophageal reflux disease on quality of life. Surg Endosc 2003;17:1193-9. [PMID: 12799881 DOI: 10.1007/s00464-002-9229-4] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 1.8] [Reference Citation Analysis]
34 Hein J. Comparison of the efficacy and safety of pantoprazole magnesium and pantoprazole sodium in the treatment of gastro-oesophageal reflux disease: a randomized, double-blind, controlled, multicentre trial. Clin Drug Investig 2011;31:655-64. [PMID: 21819161 DOI: 10.2165/11590270-000000000-00000] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
35 Lee SW, Chang CM, Chang CS, Kao AW, Chou MC. Comparison of presentation and impact on quality of life of gastroesophageal reflux disease between young and old adults in a Chinese population. World J Gastroenterol 2011; 17(41): 4614-4618 [PMID: 22147968 DOI: 10.3748/wjg.v17.i41.4614] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
36 Gorczyca R, Pardak P, Pękala A, Filip R. Impact of gastroesophageal reflux disease on the quality of life of Polish patients. World J Clin Cases 2019; 7(12): 1421-1429 [PMID: 31363470 DOI: 10.12998/wjcc.v7.i12.1421] [Cited by in CrossRef: 4] [Article Influence: 1.3] [Reference Citation Analysis]
37 Thomson A. Impact of PPIs on patient focused symptomatology in GERD. Ther Clin Risk Manag 2008;4:1185-200. [PMID: 19337426 DOI: 10.2147/tcrm.s3132] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
38 Lee YC, Yen AM, Tai JJ, Chang SH, Lin JT, Chiu HM, Wang HP, Wu MS, Chen TH. The effect of metabolic risk factors on the natural course of gastro-oesophageal reflux disease. Gut. 2009;58:174-181. [PMID: 18936105 DOI: 10.1136/gut.2008.162305] [Cited by in Crossref: 60] [Cited by in F6Publishing: 50] [Article Influence: 4.3] [Reference Citation Analysis]
39 Gatopoulou A, Mimidis K, Giatromanolaki A, Papadopoulos V, Polychronidis A, Lyratzopoulos N, Sivridis E, Minopoulos G. Impact of hiatal hernia on histological pattern of non-erosive reflux disease. BMC Gastroenterol 2005;5:2. [PMID: 15638947 DOI: 10.1186/1471-230X-5-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
40 Kang JH, Kang JY. Lifestyle measures in the management of gastro-oesophageal reflux disease: clinical and pathophysiological considerations. Ther Adv Chronic Dis. 2015;6:51-64. [PMID: 25729556 DOI: 10.1177/2040622315569501] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
41 Jeon JH, Cheung DY. [Clinical improvement of Los Angeles grade D esophagitis with proton pump inhibitor]. Korean J Gastroenterol 2014;63:134-6. [PMID: 24707550 DOI: 10.4166/kjg.2014.63.2.134] [Reference Citation Analysis]
42 Dent J, El-Serag HB, Wallander MA, Johansson S. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2005;54:710-7. [PMID: 15831922 DOI: 10.1136/gut.2004.051821] [Cited by in Crossref: 1179] [Cited by in F6Publishing: 1007] [Article Influence: 69.4] [Reference Citation Analysis]
43 Fornari F, Sifrim D. Diagnostic options for patients with refractory GERD. Curr Gastroenterol Rep. 2008;10:283-288. [PMID: 18625140 DOI: 10.1007/s11894-008-0057-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
44 Jones R, Latinovic R, Charlton J, Gulliford MC. Alarm symptoms in early diagnosis of cancer in primary care: cohort study using General Practice Research Database. BMJ 2007;334:1040. [PMID: 17493982 DOI: 10.1136/bmj.39171.637106.AE] [Cited by in Crossref: 150] [Cited by in F6Publishing: 98] [Article Influence: 10.0] [Reference Citation Analysis]
45 Lishchuk NB, Simanenkov VI, Tikhonov SV. [Differentiation therapy for non-acidic gastroesophageal reflux disease]. Ter Arkh 2017;89:57-63. [PMID: 28514401 DOI: 10.17116/terarkh201789457-63] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
46 Noh YW, Jung HK, Kim SE, Jung SA. Overlap of Erosive and Non-erosive Reflux Diseases With Functional Gastrointestinal Disorders According to Rome III Criteria. J Neurogastroenterol Motil. 2010;16:148-156. [PMID: 20535345 DOI: 10.5056/jnm.2010.16.2.148] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 4.6] [Reference Citation Analysis]
47 Felix VN, Yogi I, Senday D, Coimbra FT, Pares D, Garcia V, Garcia CE. Discussing the influence of electrode location in the result of esophageal prolonged pH monitoring. BMC Gastroenterol 2014;14:64. [PMID: 24708547 DOI: 10.1186/1471-230X-14-64] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
48 Hershcovici T, Fass R. Nonerosive Reflux Disease (NERD) - An Update. J Neurogastroenterol Motil. 2010;16:8-21. [PMID: 20535321 DOI: 10.5056/jnm.2010.16.1.8] [Cited by in Crossref: 85] [Cited by in F6Publishing: 75] [Article Influence: 7.1] [Reference Citation Analysis]
49 Heading RC, Thomas EC, Sandy P, Smith G, Fass R, Hungin PS. Discrepancies between upper GI symptoms described by those who have them and their identification by conventional medical terminology: a survey of sufferers in four countries. Eur J Gastroenterol Hepatol 2016;28:455-62. [PMID: 26735161 DOI: 10.1097/MEG.0000000000000565] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
50 Teschke R, Wolff A, Frenzel C, Eickhoff A, Schulze J. Herbal traditional Chinese medicine and its evidence base in gastrointestinal disorders. World J Gastroenterol. 2015;21:4466-4490. [PMID: 25914456 DOI: 10.3748/wjg.v21.i15.4446] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
51 Ebrahimi-Mameghani M, Sabour S, Khoshbaten M, Arefhosseini SR, Saghafi-Asl M. Total diet, individual meals, and their association with gastroesophageal reflux disease. Health Promot Perspect 2017;7:155-62. [PMID: 28695104 DOI: 10.15171/hpp.2017.28] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
52 Mearin F, Ponce J, Ponce M, Balboa A, González MA, Zapardiel J. Clinical usefulness of adherence to gastro-esophageal reflux disease guideline by Spanish gastroenterologists. World J Gastroenterol 2012; 18(35): 4885-4891 [PMID: 23002360 DOI: 10.3748/wjg.v18.i35.4885] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
53 Bixquert M. Maintenance therapy in gastro-oesophageal reflux disease. Drugs. 2005;65 Suppl 1:59-66. [PMID: 16335859 DOI: 10.1111/j.1365-2036.2007.03381.x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 56] [Article Influence: 3.7] [Reference Citation Analysis]
54 Wong WM, Lam KF, Cheng C, Hui WM, Xia HHX, Lai KC, Hu WH, Huang JQ, Lam CL, Chan CK, Chan AO, Lam SK, Wong BCY. Population based study of noncardiac chest pain in southern Chinese: Prevalence, psychosocial factors and health care utilization. World J Gastroenterol 2004; 10(5): 707-712 [PMID: 14991943 DOI: 10.3748/wjg.v10.i5.707] [Cited by in CrossRef: 60] [Cited by in F6Publishing: 58] [Article Influence: 3.3] [Reference Citation Analysis]
55 Tierney B, Iqbal A, Haider M, Filipi C. Effects of prior endoluminal gastroplication on subsequent laparoscopic Nissen fundoplication. Surg Endosc 2007;21:321-3. [PMID: 17219292 DOI: 10.1007/s00464-005-0065-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
56 Teschke R, Wolff A, Frenzel C, Eickhoff A, Schulze J. Herbal traditional Chinese medicine and its evidence base in gastrointestinal disorders. World J Gastroenterol 2015; 21(15): 4466-4490 [PMID: 25914456 DOI: 10.3748/wjg.v21.i15.4466] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 49] [Article Influence: 6.6] [Reference Citation Analysis]
57 Liu JJ, Saltzman JR. Refractory Gastro-Oesophageal Reflux Disease: Diagnosis and Management. Drugs 2009;69:1935-44. [DOI: 10.2165/11318520-000000000-00000] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
58 Röhss K, Hasselgren G, Hedenström H. Effect of esomeprazole 40 mg vs omeprazole 40 mg on 24-hour intragastric pH in patients with symptoms of gastroesophageal reflux disease. Dig Dis Sci 2002;47:954-8. [PMID: 12018920 DOI: 10.1023/a:1015009300955] [Cited by in Crossref: 71] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
59 Schmitt C, Lightdale CJ, Hwang C, Hamelin B. A multicenter, randomized, double-blind, 8-week comparative trial of standard doses of esomeprazole (40 mg) and omeprazole (20 mg) for the treatment of erosive esophagitis. Dig Dis Sci. 2006;51:844-850. [PMID: 16642422 DOI: 10.1007/s10620-005-9062-4] [Cited by in Crossref: 42] [Cited by in F6Publishing: 33] [Article Influence: 2.6] [Reference Citation Analysis]
60 Orlando RC, Liu S, Illueca M. Relationship between esomeprazole dose and timing to heartburn resolution in selected patients with gastroesophageal reflux disease. Clin Exp Gastroenterol 2010;3:117-25. [PMID: 21694855 DOI: 10.2147/CEG.S12333] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
61 Scholten T, Teutsch I, Bohuschke M, Gatz G. Pantoprazole on-demand effectively treats symptoms in patients with gastro-oesophageal reflux disease. Clin Drug Investig 2007;27:287-96. [PMID: 17358101 DOI: 10.2165/00044011-200727040-00008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
62 Pettit M. Treatment of gastroesophageal reflux disease. Pharm World Sci. 2005;27:432-435. [PMID: 16341949 DOI: 10.1007/s11096-005-4798-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
63 Grant K, Al-Adhami N, Tordoff J, Livesey J, Barbezat G, Reith D. Continuation of proton pump inhibitors from hospital to community. Pharm World Sci. 2006;28:189-193. [PMID: 17066244 DOI: 10.1007/s11096-006-9028-4] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 2.9] [Reference Citation Analysis]
64 Zhao W, Jin H, Zhang L, Wang B, Sun F, Jiao H, Sun C, Wang B. Pictograms to Provide a Better Understanding of Gastroesophageal Reflux Symptoms in Chinese Subjects. Gastroenterol Res Pract 2017;2017:1214584. [PMID: 28656044 DOI: 10.1155/2017/1214584] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
65 Dent J, El-Serag HB, Wallander MA, Johansson S. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2005;54:710-717. [PMID: 15831922 DOI: 10.1136/qut.2004.051821] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
66 Uemura N, Inokuchi H, Serizawa H, Chikama T, Yamauchi M, Tsuru T, Umezu T, Urata T, Yurino N, Tanabe S. Efficacy and safety of omeprazole in Japanese patients with nonerosive reflux disease. J Gastroenterol. 2008;43:670-678. [PMID: 18807128 DOI: 10.1007/s00535-008-2214-5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
67 Galmiche JP, Zerbib F, des Varannes SB. Treatment of GORD: Three decades of progress and disappointments. United European Gastroenterol J 2013;1:140-50. [PMID: 24917952 DOI: 10.1177/2050640613484021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
68 Conchillo JM, Schwartz MP, Selimah M, Samsom M, Sifrim D, Smout AJ. Acid and non-acid reflux patterns in patients with erosive esophagitis and non-erosive reflux disease (NERD): a study using intraluminal impedance monitoring. Dig Dis Sci. 2008;53:1506-1512. [PMID: 17934853 DOI: 10.1007/s10620-007-0059-z] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.1] [Reference Citation Analysis]
69 Nandurkar S, Talley NJ, Martin CJ, Ng T, Adams S. Esophageal histology does not provide additional useful information over clinical assessment in identifying reflux patients presenting for esophagogastroduodenoscopy. Dig Dis Sci 2000;45:217-24. [PMID: 10711428 DOI: 10.1023/a:1005449302408] [Cited by in Crossref: 41] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
70 Kumar A, Raja K, Kumar S, Quasimuddin N, Rizwan A. Quality of Life in Gastroesophageal Reflux Disease Three Months After Laparoscopic Nissen's Fundoplication. Cureus 2020;12:e10674. [PMID: 33133840 DOI: 10.7759/cureus.10674] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
71 Fass R, Tougas G. Functional heartburn: the stimulus, the pain, and the brain. Gut. 2002;51:885-892. [PMID: 12427796 DOI: 10.1136/gut.51.6.885] [Cited by in Crossref: 161] [Cited by in F6Publishing: 146] [Article Influence: 8.1] [Reference Citation Analysis]
72 Park JH, Park H, Lee DH, Sung IK. A randomized, double blinded, clinical trial to assess the efficacy and cost effectiveness of omeprazole compared to rabeprazole in the maintenance therapy of patients with gastroesophageal reflux disease. J Neurogastroenterol Motil 2013;19:219-26. [PMID: 23667753 DOI: 10.5056/jnm.2013.19.2.219] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
73 Lightdale CJ, Schmitt C, Hwang C, Hamelin B. A multicenter, randomized, double-blind, 8-week comparative trial of low-dose esomeprazole (20 mg) and standard-dose omeprazole (20 mg) in patients with erosive esophagitis. Dig Dis Sci. 2006;51:852-857. [PMID: 16773434 DOI: 10.1007/s10620-005-9071-3] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
74 Pouchain D, Bigard MA, Liard F, Childs M, Decaudin A, McVey D. Gaviscon® vs. omeprazole in symptomatic treatment of moderate gastroesophageal reflux. a direct comparative randomised trial. BMC Gastroenterol 2012;12:18. [PMID: 22361121 DOI: 10.1186/1471-230X-12-18] [Cited by in Crossref: 22] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
75 Ang TL, Fock KM, Ng TM, Teo EK, Chua TS, Tan J. A comparison of the clinical, demographic and psychiatric profiles among patients with erosive and non-erosive reflux disease in a multi-ethnic Asian country. World J Gastroenterol 2005; 11(23): 3558-3561 [PMID: 15962374 DOI: 10.3748/wjg.v11.i23.3558] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 30] [Article Influence: 1.9] [Reference Citation Analysis]
76 Kinoshita Y, Hongo M, Kusano M, Furuhata Y, Miyagishi H, Ikeuchi S; RPZ Study Group. Therapeutic Response to Twice-daily Rabeprazole on Health-related Quality of Life and Symptoms in Patients with Refractory Reflux Esophagitis: A Multicenter Observational Study. Intern Med. 2017;56:1131-1139. [PMID: 28502925 DOI: 10.2169/internalmedicine.56.7896] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
77 Katelaris P, Holloway R, Talley N, Gotley D, Williams S, Dent J; DIGESTIVE HEALTH FOUNDATION OF THE GASTROENTEROLOGICAL SOCIETY OF AUSTRALIA. Gastro-oesophageal reflux disease in adults: Guidelines for clinicians. J Gastroenterol Hepatol 2002;17:825-33. [DOI: 10.1046/j.1440-1746.2002.02839.x] [Cited by in Crossref: 34] [Article Influence: 1.7] [Reference Citation Analysis]
78 Duggan A. Management of dyspepsia at the beginning of the twenty-first century. Intern Med J 2003;33:604-9. [PMID: 14656236 DOI: 10.1111/j.1445-5994.2003.00495.x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
79 Fuchs KH, Babic B, Breithaupt W, Dallemagne B, Fingerhut A, Furnee E, Granderath F, Horvath P, Kardos P, Pointner R, Savarino E, Van Herwaarden-Lindeboom M, Zaninotto G;  European Association of Endoscopic Surgery (EAES). EAES recommendations for the management of gastroesophageal reflux disease. Surg Endosc. 2014;28:1753-1773. [PMID: 24789125 DOI: 10.1007/s00464-014-3431-z] [Cited by in Crossref: 108] [Cited by in F6Publishing: 70] [Article Influence: 13.5] [Reference Citation Analysis]
80 Gatopoulou A, Mimidis K, Giatromanolaki A, Polichronidis A, Lirantzopoulos N, Sivridis E, Minopoulos G. Impact of Helicobacter pylori infection on histological changes in non-erosive reflux disease. World J Gastroenterol 2004; 10(8): 1180-1182 [PMID: 15069722 DOI: 10.3748/wjg.v10.i8.1180] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
81 Nomura E, Kayano H, Lee SW, Kawai M, Machida T, Yamamoto S, Nabeshima K, Nakamura K, Mukai M, Uchiyama K. Functional evaluations comparing the double-tract method and the jejunal interposition method following laparoscopic proximal gastrectomy for gastric cancer: an investigation including laparoscopic total gastrectomy. Surg Today. 2019;49:38-48. [PMID: 30159780 DOI: 10.1007/s00595-018-1699-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
82 Kamolz T, Granderath FA, Schweiger UM, Pointner R. Laparoscopic Nissen fundoplication in patients with nonerosive reflux disease. Long-term quality-of-life assessment and surgical outcome. Surg Endosc 2005;19:494-500. [PMID: 15959712 DOI: 10.1007/s00464-003-9267-6] [Cited by in Crossref: 50] [Cited by in F6Publishing: 31] [Article Influence: 2.9] [Reference Citation Analysis]
83 Khan MQ. Helicobacter pylori Eradication Therapy in Nonulcer Dyspepsia is Beneficial. Saudi J Gastroenterol 2008;14:96-100. [PMID: 19568511 DOI: 10.4103/1319-3767.39629] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
84 Labenz J, Malfertheiner P. Treatment of uncomplicated reflux disease. World J Gastroenterol 2005; 11(28): 4291-4299 [PMID: 16038023 DOI: 10.3748/wjg.v11.i28.4291] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 29] [Article Influence: 2.4] [Reference Citation Analysis]
85 Ristic N, Milovanovic I, Radusinovic M, Stevic M, Ristic M, Ristic M, Kisic Tepavcevic D, Alempijevic T. The comparative analyses of different diagnostic approaches in detection of gastroesophageal reflux disease in children. PLoS One 2017;12:e0187081. [PMID: 29095882 DOI: 10.1371/journal.pone.0187081] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
86 Dent J, Armstrong D, Delaney B, Moayyedi P, Talley NJ, Vakil N. Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs. Gut. 2004;53 Suppl 4:iv1-i24. [PMID: 15082609 DOI: 10.1136/gut.2003.034272] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 2.9] [Reference Citation Analysis]
87 Lee SW, Lee TY, Lien HC, Peng YC, Yeh HJ, Chang CS. Correlation Between Symptom Severity and Health-Related Life Quality of a Population With Gastroesophageal Reflux Disease. Gastroenterology Res 2017;10:78-83. [PMID: 28496527 DOI: 10.14740/gr753w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
88 Revicki DA, Zodet MW, Joshua-Gotlib S, Levine D, Crawley JA. Health-related quality of life improves with treatment-related GERD symptom resolution after adjusting for baseline severity. Health Qual Life Outcomes. 2003;1:73. [PMID: 14641914 DOI: 10.1186/1477-7525-1-73] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 1.5] [Reference Citation Analysis]
89 Monroy M, Ruiz MA, Rejas J, Soto J. Mapping of the Gastrointestinal Short Form Questionnaire (GSF-Q) into EQ-5D-3L and SF-6D in patients with gastroesophageal reflux disease. Health Qual Life Outcomes 2018;16:177. [PMID: 30200982 DOI: 10.1186/s12955-018-1003-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
90 Savarino E, Zentilin P, Savarino V. NERD: an umbrella term including heterogeneous subpopulations. Nat Rev Gastroenterol Hepatol 2013;10:371-80. [DOI: 10.1038/nrgastro.2013.50] [Cited by in Crossref: 122] [Cited by in F6Publishing: 108] [Article Influence: 13.6] [Reference Citation Analysis]
91 Lopez-Alvarenga JC, Vargas JA, Lopez LH, Fass R, Sobrino-Cossio S, Higgins P, Comuzzie A. Effect of body weight and esophageal damage on the severity of gastroesophageal reflux symptoms. Mexican GERD working group. Arch Med Res 2009;40:576-81. [PMID: 20082872 DOI: 10.1016/j.arcmed.2009.08.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
92 Kim KJ, Lee BS. Central Obesity as a Risk Factor for Non-Erosive Reflux Disease. Yonsei Med J 2017;58:743-8. [PMID: 28540986 DOI: 10.3349/ymj.2017.58.4.743] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
93 Chaiteerakij R, Rerknimitr R, Kullavanijaya P. Role of digital chromoendoscopy in detecting minimal change esophageal reflux disease. World J Gastrointest Endosc 2010; 2(4): 121-129 [PMID: 21160727 DOI: 10.4253/wjge.v2.i4.121] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
94 Leodolter A, Nocon M, Kulig M, Willich SN, Malfertheiner P, Labenz J. Gastro esophageal reflux disease is associated with absence from work: results from a prospective cohort study. World J Gastroenterol 2005;11:7148-51. [PMID: 16437662 DOI: 10.3748/wjg.v11.i45.7148] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
95 Amarasiri LD, Pathmeswaran A, de Silva HJ, Ranasinha CD. Prevalence of gastro-oesophageal reflux disease symptoms and reflux-associated respiratory symptoms in asthma. BMC Pulm Med 2010;10:49. [PMID: 20843346 DOI: 10.1186/1471-2466-10-49] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
96 Talley NJ. Dyspepsia: management guidelines for the millennium. Gut 2002;50 Suppl 4:iv72-8; discussion iv79. [PMID: 11953354 DOI: 10.1136/gut.50.suppl_4.iv72] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
97 Morice AH, Kastelik JA. Cough. 1: Chronic cough in adults. Thorax 2003;58:901-7. [PMID: 14514949 DOI: 10.1136/thorax.58.10.901] [Cited by in Crossref: 80] [Cited by in F6Publishing: 69] [Article Influence: 4.2] [Reference Citation Analysis]
98 Yang SY, Lee OY, Bak YT, Jun DW, Lee SP, Lee SH, Park GT, Yoon BC, Choi HS, Hahm JS. Prevalence of gastroesophageal reflux disease symptoms and uninvestigated dyspepsia in Korea: a population-based study. Dig Dis Sci. 2008;53:188-193. [PMID: 17510800 DOI: 10.1007/s10620-007-9842-0] [Cited by in Crossref: 62] [Cited by in F6Publishing: 52] [Article Influence: 4.1] [Reference Citation Analysis]
99 Testoni PA, Corsetti M, Di Pietro S, Castellaneta AG, Vailati C, Masci E, Passaretti S. Effect of transoral incisionless fundoplication on symptoms, PPI use, and ph-impedance refluxes of GERD patients. World J Surg. 2010;34:750-757. [PMID: 20091308 DOI: 10.1007/s00268-010-0394-7] [Cited by in Crossref: 41] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]
100 Calabrese C, Fabbri A, Di Febo G. Long-term management of GERD in the elderly with pantoprazole. Clin Interv Aging. 2007;2:85-92. [PMID: 18044079 DOI: 10.2147/ciia.2007.2.1.85] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
101 Shaw MJ, Crawley JA. Improving health-related quality of life in gastro-oesophageal reflux disease. Drugs 2003;63:2307-16. [PMID: 14524732 DOI: 10.2165/00003495-200363210-00003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
102 Malfertheiner P, Lind T, Willich S, Vieth M, Jaspersen D, Labenz J, Meyer-Sabellek W, Junghard O, Stolte M. Prognostic influence of Barrett's oesophagus and Helicobacter pylori infection on healing of erosive gastro-oesophageal reflux disease (GORD) and symptom resolution in non-erosive GORD: report from the ProGORD study. Gut. 2005;54:746-751. [PMID: 15888776 DOI: 10.1136/gut.2004.042143] [Cited by in Crossref: 75] [Cited by in F6Publishing: 60] [Article Influence: 4.4] [Reference Citation Analysis]
103 Pace F, Riegler G, Leone A, Dominici P, Grossi E, Group TES. Gastroesophageal reflux disease management according to contemporary international guidelines: A translational study. World J Gastroenterol 2011; 17(9): 1160-1166 [PMID: 21448420 DOI: 10.3748/wjg.v17.i9.1160] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
104 Nwokediuko SC. Current trends in the management of gastroesophageal reflux disease: a review. ISRN Gastroenterol. 2012;2012:391631. [PMID: 22844607 DOI: 10.5402/2012/391631] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
105 Alharethy S, Baqays A, Mesallam TA, Syouri F, Al Wedami M, Aldrees T, AlQabbani A. Correlation between Allergic Rhinitis and Laryngopharyngeal Reflux. Biomed Res Int 2018;2018:2951928. [PMID: 29765981 DOI: 10.1155/2018/2951928] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
106 Liakakos T, Karamanolis G, Patapis P, Misiakos EP. Gastroesophageal reflux disease: medical or surgical treatment? Gastroenterol Res Pract. 2009;2009:371580. [PMID: 20069112 DOI: 10.1155/2009/371580] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
107 Ghisa M, Barberio B, Savarino V, Marabotto E, Ribolsi M, Bodini G, Zingone F, Frazzoni M, Savarino E. The Lyon Consensus: Does It Differ From the Previous Ones? J Neurogastroenterol Motil 2020;26:311-21. [PMID: 32606254 DOI: 10.5056/jnm20046] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
108 Mostaghni A, Mehrabani D, Khademolhosseini F, Masoumi SJ, Moradi F, Zare N, Saberi-Firoozi M. Prevalence and risk factors of gastroesophageal reflux disease in Qashqai migrating nomads, southern Iran. World J Gastroenterol 2009; 15(8): 961-965 [PMID: 19248195 DOI: 10.3748/wjg.15.961] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
109 Viazis N, Karamanolis G, Vienna E, Karamanolis DG. Selective-serotonin reuptake inhibitors for the treatment of hypersensitive esophagus. Therap Adv Gastroenterol 2011;4:295-300. [PMID: 21922028 DOI: 10.1177/1756283X11409279] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
110 Talley NJ, Wiklund I. Patient reported outcomes in gastroesophageal reflux disease: an overview of available measures. Qual Life Res 2005;14:21-33. [PMID: 15789938 DOI: 10.1007/s11136-004-0613-5] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
111 Jones MP. Acid suppression in gastro-oesophageal reflux disease: Why? How? How much and when? Postgrad Med J. 2002;78:465-468. [PMID: 12185218 DOI: 10.1136/pmj.78.922.465] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
112 Wahlqvist P, Junghard O, Higgins A, Green J. Cost effectiveness of esomeprazole compared with omeprazole in the acute treatment of patients with reflux oesophagitis in the UK. Pharmacoeconomics 2002;20:279-87. [PMID: 11950384 DOI: 10.2165/00019053-200220040-00006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
113 Jo SY, Kim N, Lim JH, Shin CM, Park YS, Lee DH, Jung HC. Comparison of gastroesophageal reflux disease symptoms and proton pump inhibitor response using gastroesophageal reflux disease impact scale questionnaire. J Neurogastroenterol Motil 2013;19:61-9. [PMID: 23350049 DOI: 10.5056/jnm.2013.19.1.61] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
114 Dent J. Definitions of reflux disease and its separation from dyspepsia. Gut 2002;50 Suppl 4:iv17-20; discussion iv21-2. [PMID: 11953340 DOI: 10.1136/gut.50.suppl_4.iv17] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
115 Mathai S, Datta K, Adhikari K. A study of the effect of nasal modes of ventilation on the incidence of gastro-oesophageal reflux in preterm neonates. Med J Armed Forces India 2012;68:12-5. [PMID: 24669032 DOI: 10.1016/S0377-1237(11)60123-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
116 des Varannes SB, Mion F, Ducrotté P, Zerbib F, Denis P, Ponchon T, Thibault R, Galmiche JP. Simultaneous recordings of oesophageal acid exposure with conventional pH monitoring and a wireless system (Bravo). Gut. 2005;54:1682-1686. [PMID: 15843417 DOI: 10.1136/gut.2005.066274] [Cited by in Crossref: 71] [Cited by in F6Publishing: 55] [Article Influence: 4.2] [Reference Citation Analysis]
117 Chowdhury SD, George G, Ramakrishna K, Ramadass B, Pugazhendhi S, Mechenro J, Jeyaseelan L, Ramakrishna BS. Prevalence and factors associated with gastroesophageal reflux disease in southern India: A community-based study. Indian J Gastroenterol 2019;38:77-82. [PMID: 30790137 DOI: 10.1007/s12664-018-00931-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 3.7] [Reference Citation Analysis]
118 Matheson AJ, Jarvis B. Lansoprazole: an update of its place in the management of acid-related disorders. Drugs. 2001;61:1801-1833. [PMID: 11693467 DOI: 10.2165/00003495-200161120-00011] [Cited by in Crossref: 45] [Cited by in F6Publishing: 33] [Article Influence: 2.3] [Reference Citation Analysis]
119 Cheung TK, Wong BC, Lam SK. Gastro-oesophageal reflux disease in Asia: birth of a ‘new’ disease? Drugs. 2008;68:399-406. [PMID: 18318559 DOI: 10.2165/00003495-200868040-00001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
120 Altomare A, Guarino MPL, Cocca S, Emerenziani S, Cicala M. Gastroesophageal reflux disease: Update on inflammation and symptom perception. World J Gastroenterol 2013; 19(39): 6523-6528 [PMID: 24151376 DOI: 10.3748/wjg.v19.i39.6523] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 37] [Article Influence: 4.8] [Reference Citation Analysis]
121 Li W, Zhang ST, Yu ZL. Clinical and endoscopic features of Chinese reflux esophagitis patients. World J Gastroenterol 2008; 14(12): 1866-1871 [PMID: 18350624 DOI: 10.3748/wjg.14.1866] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
122 Prasad M, Rentz AM, Revicki DA. The impact of treatment for gastro-oesophageal reflux disease on health-related quality of life: a literature review. Pharmacoeconomics 2003;21:769-90. [PMID: 12859219 DOI: 10.2165/00019053-200321110-00002] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 1.7] [Reference Citation Analysis]
123 Thjodleifsson B. Treatment of acid-related diseases in the elderly with emphasis on the use of proton pump inhibitors. Drugs Aging 2002;19:911-27. [PMID: 12495367 DOI: 10.2165/00002512-200219120-00003] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
124 Choi JS, Kim HM, Yang YJ, Lee S, Jeong SH, Han KJ. Fatty liver disease and the risk of erosive oesophagitis in the Korean population: a cross-sectional study. BMJ Open 2019;9:e023585. [PMID: 30705240 DOI: 10.1136/bmjopen-2018-023585] [Reference Citation Analysis]
125 Seo HS, Choi M, Son SY, Kim MG, Han DS, Lee HH. Evidence-Based Practice Guideline for Surgical Treatment of Gastroesophageal Reflux Disease 2018. J Gastric Cancer. 2018;18:313-327. [PMID: 30607295 DOI: 10.5230/jgc.2018.18.e41] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
126 Netinatsunton N, Sottisuporn J, Attasaranya S, Witeerungrot T, Chamroonkul N, Jongboonyanuparp T, Geater A, Ovartlarnporn B. i-Scan detection of minimal change esophagitis in dyspeptic patients with or without Gastroesophageal Reflux disease. BMC Gastroenterol 2016;16:4. [PMID: 26762316 DOI: 10.1186/s12876-016-0417-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]